Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Name: Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN
Published: 2018
License: Public Domain

Jacqueline Garcia, MD · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

acute myeloid leukemia (aml), myelodysplastic syndrome (mds), chronic myelomonocytic leukemia (cmml), mds/myeloproliferative neoplasm-unclassifiable (mds/mpn-unclassifiable), hematopoietic stem cell transplant, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Related documents